Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. It operates in the diabetes and other metabolic diseases field. The Company's proprietary technological platform known as BioChaperone is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.